Related Experiment Video
Updated: Jul 10, 2026
03:42
A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction
Published on: March 29, 2024
[Severe progression of coronary heart disease in a patient with elevated lipoprotein (a) level in spite of optimal
Sabine Fischer1, Ulrich Julius, Sybille Bergmann
1Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden. sabine.fischer@uniklinikum-dresden.de
Herz
|November 1, 2007
Summary
A massively elevated lipoprotein (a) level significantly increases the risk of early-onset arteriosclerosis. Intensive management of all cardiovascular risk factors, including strict LDL-C control, is crucial for patients with high lipoprotein (a).
Area of Science:
- Cardiology
- Lipid Metabolism
- Vascular Biology
Context:
- A 39-year-old patient with a history of myocardial infarction and coronary two-vessel disease presented with significantly elevated lipoprotein (a) levels.
- Despite percutaneous transluminal coronary angioplasty (PTCA), stent implantation, and atorvastatin therapy, the patient experienced restenosis and unstable angina pectoris.
Purpose:
- To highlight the critical role of elevated lipoprotein (a) as a risk factor for progressive arteriosclerosis.
- To emphasize the importance of comprehensive risk factor management in patients with hyperlipoproteinemia.
Summary:
- The case illustrates recurrent in-stent restenosis and the need for aggressive lipid-lowering therapy (atorvastatin 80 mg/d, ezetimibe 10 mg/d) targeting LDL-C < 100 mg/dl.
- Despite smoking cessation and blood pressure control, obesity persisted, underscoring the multifactorial nature of cardiovascular disease progression.
Impact:
- Elevated lipoprotein (a) necessitates lifelong monitoring and aggressive management of all cardiovascular risk factors.
- Strict control of LDL-C levels (< 100 mg/dl, optionally < 70 mg/dl) and other factors like hypertension and diabetes is vital.
- Nicotinic acid derivatives can reduce lipoprotein (a) levels, and regular cardiologic and angiologic assessments are integral to patient care.
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:38Inflammation
Overview
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...